Alnylam Pharmaceuticals Overview
Alnylam Pharmaceuticals Target Price
Analysts' 12-month price predictions for ALNY.
Share Price
$326.09
Average Target Price
$349.00
7% upside
7% upside2 analysts in the last 4 months
High: $360 | Low: $338
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-24 | BMO CapitalKostas Biliouris | $360 | 10.4% upside |  |
| 2025-03-21 | Scotiabank | $338 | 3.7% upside | |
| 2025-01-07 | BernsteinWilliam Pickering | $310 |  4.9% downside | |
| 2024-10-24 | Canaccord GenuityWhitney Ijem | $336 | 3% upside | |
| 2024-10-01 | Canaccord GenuityWhitney Ijem | $366 | 12.2% upside | |
| 2024-09-27 | Bank of America SecuritiesTazeen Ahmad | $307 | 5.9% downside | |
| 2024-08-27 | BMO CapitalKostas Biliouris | $300 | 8% downside | |
| 2024-08-26 | RBC CapitalLuca Issi | $300 | 8% downside | |
| 2024-08-16 | Goldman SachsSalveen Richter | $370 | 13.5% upside | |
| 2024-07-08 | Canaccord GenuityWhitney Ijem | $357 | 9.5% upside | |
| 2024-06-28 | UBSEsther Rajavelu | $288 | 11.7% downside | |
| 2024-06-27 | RBC CapitalLuca Issi | $265 | 18.7% downside | |
| 2024-06-27 | Stifel NicolausPaul Matteis | $295 | 9.5% downside | |
| 2024-06-25 | Evercore ISILiisa Bayko | $260 | 20.3% downside | |
| 2024-06-25 | RBC CapitalLuca Issi | $250 | 23.3% downside | |
| 2024-06-24 | Morgan StanleyAndrew Galler | $250 | 23.3% downside | |
| 2024-06-24 | H.C. WainwrightPatrick Trucchio | $400 | 22.7% upside | |
| 2024-06-24 | Stifel NicolausPaul Matteis | $247 | 24.3% downside | |
| 2024-06-12 | RBC CapitalLuca Issi | $235 | 27.9% downside | |
| 2024-04-08 | BMO CapitalKostas Biliouris | $234 | 28.2% downside | |
| 2022-12-15 | Piper SandlerEdward Tenthoff | $253 | 22.4% downside | |
| 2022-07-12 | Cantor FitzgeraldOlivia Brayer | $175 | 46.3% downside | |
| 2022-06-14 | Piper SandlerEdward Tenthoff | $208 | 36.2% downside | |
| 2022-05-02 | H.C. Wainwright | $430 | 31.9% upside | |
| 2022-04-29 | BMO Capital | $166 | 49.1% downside | |
| 2022-04-29 | Citigroup | $211 | 35.3% downside | |
| 2022-04-29 | Leerink Partners | $96 | 70.6% downside | |
| 2022-04-25 | Morgan Stanley | $178 | 45.4% downside | |
| 2022-02-11 | Berenberg BankZhiqiang Shu | $154 | 52.8% downside | |
| 2022-02-11 | BMO CapitalGary Nachman | $175 | 46.3% downside | |
| 2022-02-10 | RBC CapitalLuca Issi | $225 | 31% downside | |
| 2022-02-03 | GuggenheimDebjit Chattopadhyay | $170 | 47.9% downside | |
| 2022-01-26 | Bank of America SecuritiesTazeen Ahmad | $209 | 35.9% downside | |
| 2022-01-23 | JefferiesMaury Raycroft | $205 | 37.1% downside | |
| 2021-12-13 | Cowen & Co.Ritu Baral | $250 | 23.3% downside | |
| 2021-11-22 | Goldman SachsSalveen Richter | $273 | 16.3% downside | |
| 2021-10-29 | UBSEsther Rajavelu | $211 | 35.3% downside | |
| 2021-10-29 | Cantor FitzgeraldAlethia Young | $275 | 15.7% downside | |
| 2021-10-29 | Evercore ISIManeka Mirchandaney | $190 | 41.7% downside | |
| 2021-10-28 | BarclaysGena Wang | $210 | 35.6% downside | |